Cargando…

Endometriosis and COVID-19: A Systematic Review and Meta-Analysis

Endometriosis is defined as ectopic endometrial tissues dispersed outside the endometrium. This can cause disruption in hormonal and immunological processes, which may increase susceptibility to SARS-CoV-2 infection. Worsening of endometriosis symptoms may occur as a result of this infection. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabani, Ziyaana, Ramos-Nino, Maria E., Ramdass, Prakash V. A. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657778/
https://www.ncbi.nlm.nih.gov/pubmed/36361745
http://dx.doi.org/10.3390/ijms232112951
_version_ 1784829782125445120
author Kabani, Ziyaana
Ramos-Nino, Maria E.
Ramdass, Prakash V. A. K.
author_facet Kabani, Ziyaana
Ramos-Nino, Maria E.
Ramdass, Prakash V. A. K.
author_sort Kabani, Ziyaana
collection PubMed
description Endometriosis is defined as ectopic endometrial tissues dispersed outside the endometrium. This can cause disruption in hormonal and immunological processes, which may increase susceptibility to SARS-CoV-2 infection. Worsening of endometriosis symptoms may occur as a result of this infection. The aim of our review was to estimate the pooled prevalence of SARS-CoV-2 infection and the health impacts of the COVID-19 pandemic in endometriosis patients. We conducted a systematic review and meta-analysis. MEDLINE, Science Direct, Scopus, and Google Scholar databases were searched, using the keywords: (endometriosis) AND (COVID-19 OR SARS-CoV-2). Forest plots and pooled estimates were created using the Open Meta Analyst software. After screening 474 articles, 19 studies met the eligibility criteria for the systematic review, and 15 studies were included in the meta-analyses. A total of 17,799 patients were analyzed. The pooled prevalence of SARS-CoV-2 infection in endometriosis patients was 7.5%. Pooled estimates for the health impacts were 47.2% for decreased access to medical care, 49.3% increase in dysmenorrhea, 75% increase in anxiety, 59.4% increase in depression, and 68.9% increase in fatigue. Endometriosis patients were undeniably impacted by the COVID-19 pandemic, which caused the worsening of symptoms such as dysmenorrhea, pelvic pain, anxiety, depression, and fatigue.
format Online
Article
Text
id pubmed-9657778
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96577782022-11-15 Endometriosis and COVID-19: A Systematic Review and Meta-Analysis Kabani, Ziyaana Ramos-Nino, Maria E. Ramdass, Prakash V. A. K. Int J Mol Sci Review Endometriosis is defined as ectopic endometrial tissues dispersed outside the endometrium. This can cause disruption in hormonal and immunological processes, which may increase susceptibility to SARS-CoV-2 infection. Worsening of endometriosis symptoms may occur as a result of this infection. The aim of our review was to estimate the pooled prevalence of SARS-CoV-2 infection and the health impacts of the COVID-19 pandemic in endometriosis patients. We conducted a systematic review and meta-analysis. MEDLINE, Science Direct, Scopus, and Google Scholar databases were searched, using the keywords: (endometriosis) AND (COVID-19 OR SARS-CoV-2). Forest plots and pooled estimates were created using the Open Meta Analyst software. After screening 474 articles, 19 studies met the eligibility criteria for the systematic review, and 15 studies were included in the meta-analyses. A total of 17,799 patients were analyzed. The pooled prevalence of SARS-CoV-2 infection in endometriosis patients was 7.5%. Pooled estimates for the health impacts were 47.2% for decreased access to medical care, 49.3% increase in dysmenorrhea, 75% increase in anxiety, 59.4% increase in depression, and 68.9% increase in fatigue. Endometriosis patients were undeniably impacted by the COVID-19 pandemic, which caused the worsening of symptoms such as dysmenorrhea, pelvic pain, anxiety, depression, and fatigue. MDPI 2022-10-26 /pmc/articles/PMC9657778/ /pubmed/36361745 http://dx.doi.org/10.3390/ijms232112951 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kabani, Ziyaana
Ramos-Nino, Maria E.
Ramdass, Prakash V. A. K.
Endometriosis and COVID-19: A Systematic Review and Meta-Analysis
title Endometriosis and COVID-19: A Systematic Review and Meta-Analysis
title_full Endometriosis and COVID-19: A Systematic Review and Meta-Analysis
title_fullStr Endometriosis and COVID-19: A Systematic Review and Meta-Analysis
title_full_unstemmed Endometriosis and COVID-19: A Systematic Review and Meta-Analysis
title_short Endometriosis and COVID-19: A Systematic Review and Meta-Analysis
title_sort endometriosis and covid-19: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657778/
https://www.ncbi.nlm.nih.gov/pubmed/36361745
http://dx.doi.org/10.3390/ijms232112951
work_keys_str_mv AT kabaniziyaana endometriosisandcovid19asystematicreviewandmetaanalysis
AT ramosninomariae endometriosisandcovid19asystematicreviewandmetaanalysis
AT ramdassprakashvak endometriosisandcovid19asystematicreviewandmetaanalysis